New Breeding Technology (NBT) refers to gene editing technologies that are used to develop crop plants with beneficial traits, from biotic/abiotic resistance to nutritional enhancement, including zinc finger nucleases (ZFN), transcription activator-like effector nucleases, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9, meganucleases, and oligo directed mutagenesis. A total of 1,119 valid NBT patents were analyzed in this study to examine global trends in the patent and market expansion strategies for major patent applicants. Based on the claims specified, valid patents in each patent office were analyzed through the applicant’s country of origin, field of technology, and plant/crop species. Patents claiming applications of CRISPR-based technology to major crop plants, including rice, corn, wheat, tomato, and canola, have rapidly increased in the China National Intellectual Property Administration (CNIPA) since 2013. The patent family size (PFS) can be used as an indicator of intellectual property (IP)-based market expansion strategies and target markets of interests of patent applicants. Many university- and research-oriented institution Chinese applicants showed low PFS (2.1) because they filed patents mostly in CNIPA. In contrast, high PFS of US and German (DE) applicants such as Corteva Agriscience (US), KWS SAAT AG (DE), Cellectics (FR), and Syngenta Participations AG (CH) represented their active strategies for global gene-edited crop market expansion. Corteva Agriscience (US, 238 patents) was the global leader in patents using NBT, ranging from ZFN to CRISPR-based technologies applied to most major crops, including corn, soybean, and wheat.

Recently, several attempts have been undertaken to develop breeding technologies by combining new biotechnologies. Gene-editing technology is currently one of the most interesting areas. The plant breeding methods using this technique have the advantage of greatly improved accuracy and efficiency of the plant genetic correction compared with conventional breeding methods, which has raised expectations for the useful application of this technology as a cutting-edge breeding technology. Although not all countries around the world currently have established appropriate regulation policies on crops developed with gene-editing technology, the number of cases in which GMO regulations are not applied on a case-by-case basis according to the scientific background is growing. However, Korea has not yet established policies on which criteria should be applied to crops generated from the application of gene-editing technology. As the number of cases of crop development and commercialization using gene-editing technology is expected to increase in the near future, it will be necessary to prepare reasonable policies to support developers and seed industries in Korea to ensure harmonization with international regulatory policy trends.